Alto Neuroscience Inc.
€17.57
EUR
Last updated on --.
24h volume153.20K
24h highest18.5760 EUR
24h lowest17.3892 EUR
24h Price movement-2.94%
ANRO recent prices
24 Hours
-2.94%-€0.5332
30 days
-14.96%-€3.148
60 days
+4.15%+€0.7138
90 days
+5.69%+€0.9632
Key data
Previous close18.1116 EUR
Market cap627.16M EUR
Volume153.20K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.8232 EUR
Net income (FY)-63.90M EUR
Revenue (FY)--
Last report dateMay 13, 2026
About Alto Neuroscience Inc.
HeadquartersMOUNTAIN VIEW
Employees (FY)68.00
Net income per employee (FY)-939.75K EUR
Listed onNew York Stock Exchange
ANRO conversion tables
 |  |
|---|---|
| 0.5 ANRO | 8.789 EUR |
| 1 ANRO | 17.57 EUR |
| 5 ANRO | 87.89 EUR |
| 10 ANRO | 175.78 EUR |
| |
|---|---|
| 0.5 EUR | 0.028444 ANRO |
| 1 EUR | 0.056888 ANRO |
| 5 EUR | 0.28444 ANRO |
| 10 EUR | 0.56888 ANRO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ANRO is trading at €17.57, -2.94% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ANRO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ANRO is currently trading at €17.57, -2.94% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ANRO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ANRO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ANRO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ANRO's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Alto Neuroscience Inc.'s market cap is currently 627.16M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume153.20K
24h highest18.5760 EUR
24h lowest17.3892 EUR
24h Price movement-2.94%
Start trade with ANRO Perpetual
Sign up to trade